Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Protein Variants

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search

Search term:

Results 1 - 10 of 14 > >>
EC Number Protein Variants Commentary Reference
Show all pathways known for 2.3.1.191Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.191D232A mutation causes a 10fold reduction in kcat and a striking increase in the KM for both substrates 696264
Show all pathways known for 2.3.1.191Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.191F41A mutation increases the KM for UDP-3-O-((3R)-3-hydroxymyristoyl)-a-D-glucosamine 30fold and kcat 5fold 696264
Show all pathways known for 2.3.1.191Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.191K194A mutation has little effect on activity 696264
Show all pathways known for 2.3.1.191Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.191K46A mutation causes 3fold increase in KM((3R)-3-hydroxymyristoyl-[acyl-carrier protein]) and has no effect on kcat 696264
Show all pathways known for 2.3.1.191Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.191M290A wild-type EcLpxD prefers (R,S)-3-hydroxymyristoyl-ACP over (R,S)-3-hydroxypalmitoyl-ACP by a factor of 3, whereas the M290A mutant has the opposite selectivity. Both wild-type and M290A EcLpxD rescue the conditional lethality of Escherichia coli RL25, a temperature-sensitive strain harboring point mutations in lpxD. Complementation with wild-type EcLpxD restores normal lipid A containing only N-linked hydroxymyristate to RL25 at 42°C, as judged by mass spectrometry, whereas the M290A mutant generates multiple lipid A species containing one or two longer hydroxy fatty acids in place of the usual (3R)-3-hydroxymyristate at positions 2 and 20 696356
Show all pathways known for 2.3.1.191Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.191M292A wild-type EcLpxD prefers (R,S)-3-hydroxymyristoyl-ACP over (R,S)-3-hydroxypalmitoyl-ACP by a factor of 3, mutant enzyme M292A prefers (R,S)-3-hydroxymyristoyl-ACP over (R,S)-3-hydroxypalmitoyl-ACP by a factor of 2.5 696356
Show all pathways known for 2.3.1.191Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.191more construction of lpx insertional knockout mutations or RNAi knock-down mutants -, 720913
Show all pathways known for 2.3.1.191Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.191more construction of lpxD1-null and lpxD2-null mutant strains, that show altered antibiotic susceptibility patterns, membrane permeability, but no innate immune responses -, 720944
Show all pathways known for 2.3.1.191Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.191N233A mutation causes a 10fold reduction in kcat and a striking increase in the KM for both substrates 696264
Show all pathways known for 2.3.1.191Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.191N240A causes less than a 2fold reduction in specific activity, when assayed at substrate concentrations at 2fold above KM with the purified proteins 696264
Results 1 - 10 of 14 > >>